Denzapine 50 mg / ml Oral Suspension

Licence information

ATC code

N05AH Diazepines, oxazepines, thiazepines and oxepines, N05AH02 clozapine

Route of supply

Product subject to prescription which may not be renewed (A)

Place of sale

Supply through pharmacies only

Conditions of Licence

DENZAPINE Official Recommendations: DENZAPINE is associated with a specific risk of agranulocytosis. Any adverse haematological effects should be notified to the Irish Medicines Board. Intrinsic to Denzapine therapy is enrolment with and monitoring by

Marketing availability

Marketed

Advertising conditions

Advertising to healthcare professionals only

Licence issued

06/03/2009